Unique ID issued by UMIN | UMIN000038210 |
---|---|
Receipt number | R000043552 |
Scientific Title | The Hokuriku Plus Familial Hypercholesterolemia Registry Study |
Date of disclosure of the study information | 2020/04/01 |
Last modified on | 2022/04/21 14:25:36 |
The Hokuriku Plus Familial Hypercholesterolemia Registry Study
The Hokuriku Plus FH Registry Study
The Hokuriku Plus Familial Hypercholesterolemia Registry Study
The Hokuriku Plus FH Registry Study
Japan |
Familial Hypercholesterolemia
Medicine in general | Cardiology | Endocrinology and Metabolism |
Others
YES
We aim to improve the prognosis of the patients with FH.
Others
investigation for thier prognosis
new ASCVD events
LDL cholesterol, seondary ASCVD events, occurrence of other diseases (hypertension, diabetes, malignancies).
Observational
Not applicable |
Not applicable |
Male and Female
Patients diagnosed with familial hypercholesterolemia per the criteria of the Japa Atherosclerosis Society
Patients whose doctors in charge consider him/her inappropriate to participate
1000
1st name | Hayato |
Middle name | |
Last name | Tada |
Kanazawa University Hospital
Department of Cardiology
920-8641
13-1 Takara-machi, Kanazawa, Japan
0762652000
ht240z@sa3.so-net.ne.jp
1st name | Hayato |
Middle name | |
Last name | Tada |
Kanazawa University Hospital
Department of Cardiology
920-8641
13-1 Takara-machi, Kanazawa, Japan
0762652000
ht240z@sa3.so-net.ne.jp
Kanazawa University Hospital Department of Cardiology
Ministry of Health, Labour and Welfare
Japanese Governmental office
Japan
Innovative Clinical Research Center, Kanazawa University
13-1 Takara-machi, Kanazawa, Japan
0762652000
hpsangak@adm.kanazawa-u.ac.jp
NO
2020 | Year | 04 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2019 | Year | 09 | Month | 08 | Day |
2020 | Year | 01 | Month | 22 | Day |
2020 | Year | 04 | Month | 01 | Day |
2024 | Year | 03 | Month | 31 | Day |
Basic variables include the date of birth, gender, height, body weight. Physical findings include cutaneous xanthomas, Achilles tendon thickness, arcus corneae, the thick ness of Achilles tendon. Family history includes the family history of premature coronary artery disease, or that of FH. Complications include hypertension, diabetes, any malignancies, ischemic or hemorrhagic stroke, or any unknown critical status. Genetic analyses include the presence and type of pathogenic mutation in FH-associated gene. Prior ASCVD include carotid atherosclerosis, coronary atherosclerosis, peripheral artery diseases, or aortic valve stenosis. Laboratory data include blood counts, total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, lipoprotein(a), apolipoproteins, plasma glucose, HbA1c, AST, ALT, ALP, LDH, BUN, Cr, uric acid, Na, K, Cl, CRP, urinalysis. Events include new onset of ASCVD(carotid atherosclerosis, coronary atherosclerosis, PAD, aortic valve stenosis), complications including hypertension, diabetes, any malignancies, ischemic or hemorrhagic stroke, or any unknown critical status.
2019 | Year | 10 | Month | 05 | Day |
2022 | Year | 04 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043552
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |